相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A multicenter prospective trial of sorafenib in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) refractory to prior sunitinib or bevacizumab
D. R. Shepard et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
reporttools:RFunctions to GenerateLATEXTables of Descriptive Statistics
Kaspar Rufibach
Journal of Statistical Software (2015)
Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma-data from the Czech registry
T. Buchler et al.
ANNALS OF ONCOLOGY (2012)
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study
E. Calvo et al.
EUROPEAN JOURNAL OF CANCER (2012)
Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases
Camillo Porta et al.
BJU INTERNATIONAL (2011)
Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies
V. Gruenwald et al.
BRITISH JOURNAL OF CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Sequence Therapy in Patients with Metastatic Renal Cell Carcinoma: Comparison of Common Targeted Treatment Options Following Failure of Receptor Tyrosine Kinase Inhibitors
Jonas Busch et al.
EUROPEAN UROLOGY (2011)
Sorafenib and sunitinib in renal cell cancer: A study based on register data.
A. E. Ambring et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
Brian I. Rini et al.
LANCET (2011)
Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma
E. Herrmann et al.
WORLD JOURNAL OF UROLOGY (2011)
Sorafenib in Patients With Metastatic Renal Cell Carcinoma Refractory to Either Sunitinib or Bevacizumab
Jorge A. Garcia et al.
CANCER (2010)
Treating the individual: The need for a patient-focused approach to the management of renal cell carcinoma
Camillo Porta et al.
CANCER TREATMENT REVIEWS (2010)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy
Michael M. Vickers et al.
UROLOGY (2010)
Sequential Therapy With Sorafenib and Sunitinib in Renal Cell Carcinoma
Arkadiusz Z. Dudek et al.
CANCER (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Giuseppe Di Lorenzo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
SEQUENTIAL USE OF THE TYROSIN KINASE INHIBITORS SORAFENIB AND SUNITINIB
Roman Heuer et al.
JOURNAL OF UROLOGY (2009)
Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
M. P. Sablin et al.
JOURNAL OF UROLOGY (2009)
Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib
Kaja Zimmermann et al.
ONCOLOGY (2009)
Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy
Ila Tamaskar et al.
JOURNAL OF UROLOGY (2008)
Efficacy of everolimus in advanced renal cell carcinoma:: a double-blind, randomised, placebo-controlled phase III trial
Robert J. Motzer et al.
LANCET (2008)
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
Bernard Escudier et al.
LANCET (2007)
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
Gary Hudes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
分享论文
